BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Dificid fidaxomicin regulatory update

FDA's Anti-Infective Drugs Advisory Committee voted 13-0 that Dificid fidaxomicin from Optimer was safe and effective at treating Clostridium difficile-associated diarrhea (CDAD). However, the panel voted 7-6 that the finding of lower recurrence of CDAD at day 31 vs.

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >